Adlai Nortye ANL
NASDAQ ANL
$15.51 +0.76 (+5.15%)
As of: Sep 4, 2026 · 2:30 PM EDT

Adlai Nortye (ANL) Shares Outstanding (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Shares Outstanding (Entity) of $103.0 million for Q4 2025, up 9.92% year-over-year from $93.7 million in Q4 2024, and up 7.46% quarter-over-quarter from $95.9 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Shares Outstanding (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Shares Outstanding (Entity) for 4 consecutive years, with $103.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Shares Outstanding (Entity) rose 9.92% year-over-year to $103.0 million; the TTM figure through Dec 2025 stood at $103.0 million (up 9.92% YoY), while the FY2025 annual figure was $103.0 million, up 9.92% from the prior year.
  • Shares Outstanding (Entity) climbed to $103.0 million in Q4 2025 per ANL's latest filing, from $95.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $103.0 million in Q4 2025 and bottomed at $25.4 million in Q4 2022.
  • Historically, Shares Outstanding (Entity) has averaged $73.3 million across 4 years, with a median of $86.0 million in 2024.
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 116.21% — and 2025, when it gained 9.92%.
  • Adlai Nortye's Shares Outstanding (Entity) stood at $25.4 million in 2022, then soared by 70.37% to $43.3 million in 2023, then soared by 116.21% to $93.7 million in 2024, then advanced by 9.92% to $103.0 million in 2025.
  • Business Quant data shows ANL's Shares Outstanding (Entity) at $103.0 million in Q4 2025, $95.9 million in Q2 2025, and $93.7 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 210.89 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 445.06 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 217.35 Mn
10 Adlai Nortye 494.65 Mn 262.76 Mn - 31.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.97 Mn
Dec 31, 2025 31.97 Mn
Jun 30, 2025 31.93 Mn
Dec 31, 2024 31.93 Mn
Jun 30, 2024 14.45 Mn
Dec 31, 2023 14.45 Mn
Dec 31, 2022 8.48 Mn